Precise Cooler for Donor Heart Transport
ConditionHeart Transplantation
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorCedars-Sinai Medical Center
About this trial
The investigators are doing this study to compare approaches to cold storage of donor hearts during transportation. The adjustable temperature RYOBI cooler should allow precise temperature control while reducing environmental waste and providing a cost savings benefit when compared to the commercially available, FDA-approved Paragonix SherpaPak device.
Eligibility criteria
Qualifiers
Individuals 18 years old or older are included.
Individuals undergoing isolated heart transplantation are included.
Disqualifiers
Any records flagged "break the glass" or "research opt out."
Any patients undergoing multi-organ transplantation.
Trial design
Treatments tested in this trial
- Organ transport using SherpaPak
- Ryobi cooler for Organ Transport
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov